BioAge Labs Inc. (BIOA) Revenue History
Annual and quarterly revenue from 2022 to present
BIOA Revenue Over Time (2022–2025)
BIOA Revenue Growth History
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
- FY2025 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.5M | +1.6% |
| Q1 2026 | $2.8M | +91.0% |
| Q4 2025 | $3.1M | — |
| Q3 2025 | $2.1M | — |
| Q2 2025 | $2.4M | — |
| Q1 2025 | $1.5M | — |
| Q4 2024 | $0 | — |
| Q3 2024 | $0 | — |
Multi-year avg. share of annual revenue by fiscal quarter
BIOA Revenue Analysis (2022–2025)
Current Revenue & Growth
As of September 24, 2026, BioAge Labs Inc. (BIOA) generated trailing twelve-month (TTM) revenue of $10.4 million, reflecting modest growth of +1.6% year-over-year. The most recent quarter (Q2 2026) recorded $2.5 million in revenue, down 11.6% sequentially.
Historical Growth Trajectory
BIOA's historical revenue data shows various trends over time. BioAge Labs Inc.'s highest annual revenue of $9.0 million was recorded in 2025, an all-time high.
Peer Comparison
Compared to Healthcare sector peers — including KYMR (+134.8% YoY), LNTH (+2.3% YoY), and RYTM (+53.5% YoY) — BIOA has underperformed the peer group in revenue growth. Compare BIOA vs KYMR →
BIOA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| BIOACurrent | $10M | +1.6% | - | -1031.5% | |
 KYMR | $39M | +134.8% | +2.9% | -891.3% | |
 LNTH | $1.5B | +2.3% | +35.3% | 20.2% | |
 RYTM | $190M | +53.5% | - | -101.2% | |
 VNDA | $216M | +6.0% | -2.7% | -70.0% |
BIOA Historical Revenue Data (2022–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $9.0M | - | $9.0M | 100.0% | $-92,780,000 | -1031.5% |
| 2024 | $0 | - | $0 | - | $-78,194,000 | - |
| 2023 | $0 | - | $0 | - | $-48,400,000 | - |
| 2022 | $0 | - | $0 | - | $-39,969,000 | - |
BIOA Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
4+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BIOA — Frequently Asked Questions
Quick answers to the most common questions about buying BIOA stock.
Is BIOA's revenue growth accelerating or slowing?
BIOA revenue growth is slowing. TTM revenue is $10M, up +1.6% year-over-year — below the 5-year CAGR of N/A. The deceleration suggests maturing end-markets or increased competition.
What is BIOA's revenue history from 2022 to 2026?
BioAge Labs Inc. (BIOA) revenue history spans 2022 to 2026. TTM revenue as of 2026 is $10M, growing at +1.6% YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is BIOA's long-term revenue growth rate (CAGR)?
BioAge Labs Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of +1.6% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for BIOA.
Why does BIOA's quarterly revenue fluctuate?
BIOA quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. BioAge Labs Inc.'s revenue data from 2022 to 2026 shows full historical quarterly detail on this page.
How is BIOA's revenue distributed by segment?
BIOA reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does BIOA's revenue compare to industry peers?
BioAge Labs Inc. (BIOA) with TTM revenue of $10M and +1.6% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.